PUBLISHER: Coherent Market Insights | PRODUCT CODE: 1529560
PUBLISHER: Coherent Market Insights | PRODUCT CODE: 1529560
Global microfluidic market is estimated to be valued at USD 33.1 Bn in 2024 and is expected to reach USD 88.2 Bn by 2031, exhibiting a compound annual growth rate (CAGR) of 15% from 2024 to 2031.
Report Coverage | Report Details | ||
---|---|---|---|
Base Year: | 2023 | Market Size in 2024: | US$ 33.1 Bn |
Historical Data for: | 2019 to 2023 | Forecast Period: | 2024 to 2031 |
Forecast Period 2024 to 2031 CAGR: | 15.00% | 2031 Value Projection: | US$ 88.2 Bn |
Microfluidics is the science and technology of systems that process or manipulate small amounts of fluids, using channels with dimensions of tens to hundreds of micrometers. Generally, microfluidics involves controlling and manipulating fluids that are geometrically constrained to a small, typically sub-millimeter, scale and handling fluid samples on the (sub-microliter) scale. Over the past few decades, the field of microfluidics has grown tremendously and found applications in areas such as healthcare diagnostics, drug delivery, chemical and biological analysis. Global microfluidic market growth is driven by technological advancements in biomedical science, increased demand for point-of-care testing and rising R&D investments in the sector. However, design complexities and need for specialized manufacturing equipment can pose challenges for the market growth.
Global microfluidic market growth is driven by several factors such as growing demand for point-of-care testing and organ-on-chip devices, increasing R&D funding and private investments in microfluidics technology, rising prevalence of chronic and infectious diseases that creates need for rapid disease diagnosis. However, design complexities coupled with the need for specialized equipment for microfabrication processes can hinder workflow and adds to costs. Lack of standardized protocols and regulations can also hamper the market growth. Emerging application areas across genomics, proteomics and other fields of biomedical research can offer significant opportunities for market growth in the near future. Wider geographical access through technology miniaturization provide scope for more affordable diagnosis.
This report provides in-depth analysis of the global microfluidic market, and provides market size (USD Billion) and compound annual growth rate (CAGR%) for the forecast period (2024-2031), considering 2023 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global microfluidic market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies.
Key companies covered as a part of this study include Danaher Corporation, PerkinElmer Inc., Agilent Technologies Inc., Bio-Rad Laboratories Inc., Becton, Dickinson and Company
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
Global microfluidic market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global microfluidic market
Detailed Segmentation-